Abpro (NASDAQ:ABP) Now Covered by Analysts at Maxim Group

Maxim Group began coverage on shares of Abpro (NASDAQ:ABP) in a research note published on Monday,Benzinga reports. The firm issued a buy rating and a $4.00 price target on the stock.

Abpro Price Performance

Abpro stock opened at $0.76 on Monday. The business’s 50-day simple moving average is $1.41. Abpro has a 52 week low of $0.75 and a 52 week high of $13.00.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC purchased a new position in Abpro in the 4th quarter worth approximately $53,000. Atlas Merchant Capital LLC purchased a new stake in shares of Abpro during the 4th quarter valued at $157,000. Jane Street Group LLC bought a new stake in shares of Abpro during the 4th quarter worth $37,000. AQR Arbitrage LLC purchased a new position in Abpro in the fourth quarter worth $157,000. Finally, LMR Partners LLP bought a new position in Abpro in the fourth quarter valued at $112,000. 23.30% of the stock is currently owned by institutional investors.

About Abpro

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.